Outcome of the Board Meeting held on Thursday, May 21, 2026
NGLFINE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
NGL Fine Chem reported strong FY2026 results. Consolidated revenue grew 36% to ₹50,095.47 lakhs from ₹36,825.67 lakhs in FY2025. Net profit (PAT) surged 128% to ₹4,812.67 lakhs from ₹2,112.43 lakhs. EBITDA expanded significantly to ₹6,336.77 lakhs (vs ₹2,771.42 lakhs prior year). The board recommended a final dividend of ₹1.75 per share (₹108.12 lakhs total). Statutory auditors M/s Manek & Associates issued an Unmodified Opinion. The company appointed KD Practice Consulting Pvt. Ltd. as Internal Auditors and Sanghavi Randeria & Associates as Cost Auditor for FY2026-27. Mr. Rajesh Lawande was reappointed as Whole-Time Director (related to Mrs. Ajita Nachane, sister), and Mrs. Sarala Menon was reappointed as Independent Director, both subject to shareholder approval at the August 2026 AGM.
Exceptional financial year with near-doubling of PAT and 36% revenue growth. Unmodified auditor opinion signals clean financials. Dividend payout signals management confidence. However, non-current borrowings doubled to ₹5,640.33 lakhs (from ₹2,533.56 lakhs), indicating higher leverage. Related party appointment of Mr. Rajesh Lawande should be monitored.